GlaxoSmithKline opens manufacturing 'smart space' to accelerate technology adoption


Pharmaceutical company GlaxoSmithKline (GSK) has opened its first research and development facility designed to test new technology, with a focus on real time electronic data visualisation.

The so-called 'smart space' was designed by strategic design firm PWW to demonstrate how state-of-the-art systems and technologies can be combined in a manufacturing line and environment.

The facility is set within a 7500sq ft industrial space and is made up from a number of environments that connect together to form internal and external spaces.

A ‘sandpit’ area includes workshops, manufacturing, and collaboration areas and is designed to include interconnected spaces to support the user journey.

The space uses colour in a functional way to identify different areas within the facility and assist in the design language for the environment, signage, graphics and user interfaces.

The space also allows flexibility over the lifecycle of the research facility, allowing for constant evolution and testing of science and technology.

Describing the future of pharmaceutical manufacturing, Patrick Hyett, head of GSK’s IIM digitisation project said, “We wanted to build a facility we can point to and show the art of the possible.”

The Immersive Intelligent Manufacturing facility is now being used to accelerate technology adoption within GSK.

Join us, it's free.

Become a member to get access to:

  • Exclusive Content
  • Daily and specialised newsletters
  • Research and analysis

Join us, it’s free.

Want to read this article and others just like it? All you need to do is become a member of The Drum. Basic membership is quick, free and you will be able to receive daily news updates.